Oruka Therapeutics ORKA
NASDAQ ORKA
$93.78 +2.79 (+3.07%)
As of: Sep 4, 2026 · 3:13 PM EDT

Oruka Therapeutics (ORKA) Price to Earnings (2010 - 2024)

Analysis

Oruka Therapeutics (ORKA) Price to Earnings (2010 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Oruka Therapeutics 5.90 Bn 4.17 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -133.27
Mar 31, 2024 -81.64
Dec 31, 2023 -145.47
Sep 30, 2023 -131.53
Jun 30, 2023 -127.82
Mar 31, 2023 -137.77
Dec 31, 2022 -29.09
Sep 30, 2022 -12.72
Jun 30, 2022 -11.40
Mar 31, 2022 -10.13
Dec 31, 2021 -5.46
Sep 30, 2021 -9.05
Jun 30, 2021 -10.40
Mar 31, 2021 -12.83
Dec 31, 2020 -6.12
Sep 30, 2020 -13.42
Jun 30, 2020 -9.12
Mar 31, 2020 -3.37
Dec 31, 2019 -31.17
Sep 30, 2019 -7.38